Brief: Sight Sciences Announces $34 Mln Patent Infringement Verdict Against Alcon And Hydrus Microstent
29/04/2024 13:18
April 29 (Reuters) - Sight Sciences Inc SGHT.O :
* SIGHT SCIENCES ANNOUNCES SUCCESSFUL $34 MILLION PATENT
INFRINGEMENT VERDICT AGAINST ALCON AND ITS HYDRUS MICROSTENT FOR
MICROINVASIVE GLAUCOMA SURGERY
Source text for Eikon: ID:nGNX7FkmwZ
Further company coverage: SGHT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sight Sciences
See all newsSight Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Sight Sciences Q2 revenue rises 20%, beats estimates
Brief: Sight Sciences Q2 Revenue USD 23.4 Million Vs. IBES Estimate USD 21.7 Million
Sight Sciences, Inc. expected to post a loss of 15 cents a share - Earnings Preview
Sight Sciences raises FY 2026 revenue outlook